None listed
Conditions
Brief summary
The aim of this prospective study is to evaluate the results of polidocanol sclerotherapy of pharynx for OSAS & SS,to reduce pharyngeal compliance.
Interventions
Polysomnography (PSG) and 1% Polidocanol--submucosous sclerosis in the part of pharyngx with 1% polidocanol injection
The duration : about 4~5 years
Each patient with OSAS will be followed up 2 years after treatment.
The injection administered is during the treatment, the injection should be in the retrophargngeal submucosa and lateral pharyngeal bands and lateral pharyngeal submucosa and in front submucosa of soft palate. The injection is multi-point, and each point injection is 0.3~0.5ml, the
Polysomnography (PSG) and 1% Polidocanol--submucosous sclerosis in the part of pharyngx with 1% polidocanol injection The duration : about 4~5 years Each patient with OSAS will be followed up 2 years after treatment. The injection administered is during the treatment, the injection should be in the retrophargngeal submucosa and lateral pharyngeal bands and lateral pharyngeal submucosa and in front submucosa of soft palate. The injection is multi-point, and each point injection is 0.3~0.5ml, the total quantity/each time is not more than 5ml; Every patient have to be treated about 1~2 times. -------The duration of the study is 4~5 years.the treatment is only during 1~3 months.The follow-up-2-year is carried on polysomnography and clinical study-observarion.
Sponsors
Youliang Yin
Study design
Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Treatment
Masking
Open (masking not used)
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
OSAS & ,SS which palatopharyngeal collapse.
Exclusion criteria
Obstructive sleep apnea syndrom (OSAS) & snoring subjects (SS),which anatomic narrow result.
Outcome results
None listed